Atalanta Sosnoff Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Atalanta Sosnoff Capital's AMGN Position: Q2 2026 in Review
Atalanta Sosnoff Capital reduced its Amgen (AMGN) stake by 12% in Q2 2026, selling an estimated $39.4K and leaving 863 shares worth $313K. The position accounts for 0.01% of the portfolio, ranked #100.
Atalanta Sosnoff Capital first reported a position in AMGN in Q4 2014 and has held it in 13 quarters since. The position peaked at $43M in Q4 2014. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Atalanta Sosnoff Capital held 863 shares of Amgen worth $313K as of Q2 2026.
- Atalanta Sosnoff Capital sold 115 Amgen shares in Q2 2026, an estimated $39.4K.
- Amgen made up 0.01% of Atalanta Sosnoff Capital's portfolio in Q2 2026, its #100 holding.
- Atalanta Sosnoff Capital first reported a position in Amgen in Q4 2014 and has held it in 13 quarters since.
- Atalanta Sosnoff Capital's Amgen position peaked at $43M in Q4 2014.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Atalanta Sosnoff Capital's 13F filing for Q2 2026, filed 12 Aug 2026.